OVID
Ovid Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.97
-0.04 ▼ -1.99%
🌙 3월 13일 7:42 PM ET (한국 3/14 08:42)
$1.99
+0.02 ▲ +0.99%
| Index | - | P/E | - | EPS (ttm) | -0.51 | Insider Own | 11.27% | Shs Outstand | 0.13B | Perf Week | 3.14% |
| Market Cap | 0.26B | Forward P/E | - | EPS next Y | 5.86% | Insider Trans | -0.14% | Shs Float | 0.12B | Perf Month | 23.9% |
| Enterprise Value | 0.24B | PEG | - | EPS next Q | -0.12 | Inst Own | 51.8% | Short Float | 4.41% | Perf Quarter | 21.6% |
| Income | -0.04B | P/S | 38.8 | EPS this Y | -29.03% | Inst Trans | 14.16% | Short Ratio | 3.09 | Perf Half Y | 57.6% |
| Sales | 0.01B | P/B | 3.14 | EPS next 5Y | -13.2% | ROA | -43.64% | Short Interest | 5.09M | Perf YTD | 20.86% |
| Book/sh | 0.63 | P/C | 10.02 | EPS past 3/5Y | - 24.72% | ROE | -60.06% | 52W High | -16.88% ($2.37) | Perf Year | 347.73% |
| Cash/sh | 0.2 | P/FCF | - | Sales past 3/5Y | -86.05% - | ROIC | -63.68% | 52W Low | 712.37% ($0.24) | Perf 3Y | -1.99% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -11.3% | Gross Margin | 93.9% | Volatility(W/M) | 11.96% 8.56% | Perf 5Y | -51.95% |
| Dividend TTM | - | EV/Sales | 37.01 | Sales Y/Y TTM | 946.61% | Oper. Margin | -618.28% | ATR (14) | 0.15 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.24 | EPS Q/Q | 13.33% | Profit Margin | -549.62% | RSI (14) | 62.6 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.24 | Sales Q/Q | -23.7% | SMA20 | 14.94% ($1.71) | Beta | 0.08 | Target Price | $4.23 |
| Payout | - | Debt/Eq | 0.31 | Earnings | 11000000 | SMA50 | 18.6% ($1.66) | Rel Volume | 0.58 | Prev Close | $2.01 |
| Employees | 23 | LT Debt/Eq | 0.28 | EPS/Sales Surpr. | -13.41% -32.2% | SMA200 | 62.49% ($1.21) | Avg Volume(3M) | 1.65M | Price | $1.97 |
| IPO | 2017/5/5 | Option/Short | Yes/Yes | Trades | 2796 | Volume | 954,973 | Change | -1.99% |
뉴스 로딩 중...